Several of the identified loci have been implicated in ASCVD risk factors such as circulating lipids (LPA-PLG, APOE, TRIB1, KANK2), diabetes (CDKN2B-AS1, IGF2BP1) and obesity (LEPR, IGF2BP1). This evidence concerns the gene KANK2 and atherosclerosis.